After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.

This report comes from NBC News. The story centres on After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from NBC News and related outlets covering this beat.